Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARGAN INCAGX · Entity 3828 | Director · PRESIDENT AND CEO | June 15, 2026 | June 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARGAN INC
Report date June 15, 2026 · Filed June 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,005 |
Ending reported balance
After 2026-06-16 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-06-15 · Sale · Disposed 9,993 · Balance 40,005 F1: On June 15, 2026, the Reporting Person sold 9,993 shares of the Issuer's common stock on the open market at an average price of $651.22 per share. Row 2 · 2026-06-16 · Exercise / conversion · Acquired 862 · Balance 40,867 F2: On June 16, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 17, 2023 to purchase 1,666 shares of the Issuer's common stock at a price of $39.47 per share using the net settle method. Row 3 · 2026-06-16 · Exercise / conversion · Acquired 588 · Balance 41,455 F3: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method. Row 4 · 2026-06-16 · Exercise / conversion · Acquired 430 · Balance 41,885 F4: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2025 to purchase 667 shares of the Issuer's common stock at a price of $148.72 per share using the net settle method. Row 5 · 2026-06-16 · Sale · Disposed 1,880 · Balance 40,005 F5: On June 16, 2026 the Reporting Person sold 1,880 shares of the Issuer's common stock on the open market at an average price of $707.35 per share. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $39.47 · Expires 2033-04-17 | Direct | 4,415 |
Reported balance
After 2026-06-16 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-06-16 · Exercise / conversion · Disposed 1,666 · Balance 4,415 F2: On June 16, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 17, 2023 to purchase 1,666 shares of the Issuer's common stock at a price of $39.47 per share using the net settle method. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $61.22 · Expires 2034-04-16 | Direct | 3,415 |
Reported balance
After 2026-06-16 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-06-16 · Exercise / conversion · Disposed 1,000 · Balance 3,415 F3: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $148.72 · Expires 2035-04-16 | Direct | 2,748 |
Reported balance
After 2026-06-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-06-16 · Exercise / conversion · Disposed 667 · Balance 2,748 F4: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2025 to purchase 667 shares of the Issuer's common stock at a price of $148.72 per share using the net settle method. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 15, 2026, the Reporting Person sold 9,993 shares of the Issuer's common stock on the open market at an average price of $651.22 per share.
F2: On June 16, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 17, 2023 to purchase 1,666 shares of the Issuer's common stock at a price of $39.47 per share using the net settle method.
F3: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method.
F4: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2025 to purchase 667 shares of the Issuer's common stock at a price of $148.72 per share using the net settle method.
F5: On June 16, 2026 the Reporting Person sold 1,880 shares of the Issuer's common stock on the open market at an average price of $707.35 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 16, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 667 | $148.72 Strike: $148.72 | $99,196.24 |
DisclosureSEC source: 0001482442-26-000012 · form4-06162026_040603.xml · derivative · entry 8 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,748 Underlying: Common Stock · 667 shares Expires 2035-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2025 to purchase 667 shares of the Issuer's common stock at a price of $148.72 per share using the net settle method. Read SEC document |
| June 16, 2026 Filed Jun 16, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 1,000 | $61.22 Strike: $61.22 | $61,220.00 |
DisclosureSEC source: 0001482442-26-000012 · form4-06162026_040603.xml · derivative · entry 7 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,415 Underlying: Common Stock · 1,000 shares Expires 2034-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method. Read SEC document |
| June 16, 2026 Filed Jun 16, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 1,666 | $39.47 Strike: $39.47 | $65,757.02 |
DisclosureSEC source: 0001482442-26-000012 · form4-06162026_040603.xml · derivative · entry 6 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,415 Underlying: Common Stock · 1,666 shares Expires 2033-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On June 16, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 17, 2023 to purchase 1,666 shares of the Issuer's common stock at a price of $39.47 per share using the net settle method. Read SEC document |
| June 16, 2026 Filed Jun 16, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 1,880 | $707.35 | $1,329,818.00 |
DisclosureSEC source: 0001482442-26-000012 · form4-06162026_040603.xml · nonDerivative · entry 5 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,005 F5 · shares: On June 16, 2026 the Reporting Person sold 1,880 shares of the Issuer's common stock on the open market at an average price of $707.35 per share. Read SEC document |
| June 16, 2026 Filed Jun 16, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 430 | $148.72 | $63,949.60 |
DisclosureSEC source: 0001482442-26-000012 · form4-06162026_040603.xml · nonDerivative · entry 4 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2025 to purchase 667 shares of the Issuer's common stock at a price of $148.72 per share using the net settle method. Read SEC document |
| June 16, 2026 Filed Jun 16, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 588 | $61.22 | $35,997.36 |
DisclosureSEC source: 0001482442-26-000012 · form4-06162026_040603.xml · nonDerivative · entry 3 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method. Read SEC document |
| June 16, 2026 Filed Jun 16, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 862 | $39.47 | $34,023.14 |
DisclosureSEC source: 0001482442-26-000012 · form4-06162026_040603.xml · nonDerivative · entry 2 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On June 16, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 17, 2023 to purchase 1,666 shares of the Issuer's common stock at a price of $39.47 per share using the net settle method. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 9,993 | $651.22 | $6,507,641.46 |
DisclosureSEC source: 0001482442-26-000012 · form4-06162026_040603.xml · nonDerivative · entry 1 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,005 F1 · shares: On June 15, 2026, the Reporting Person sold 9,993 shares of the Issuer's common stock on the open market at an average price of $651.22 per share. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001482442-26-000006 · form4-04202026_050405.xml · derivative · entry 11 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,284 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 17, 2023, 10,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 5,000. F5 · derivative.expiration_date: Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 17, 2023, 10,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 5,000. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionEarnings Per Share Performance-Based Restricted Stock Units · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001482442-26-000006 · form4-04202026_050405.xml · derivative · entry 10 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,839 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Pursuant to three-year performance period vesting schedule of the Earnings Per Share Performance-Based Restricted Stock Units ("ERSUs") awarded to the Reporting Person on April 17, 2023, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 10,000. F4 · derivative.expiration_date: Pursuant to three-year performance period vesting schedule of the Earnings Per Share Performance-Based Restricted Stock Units ("ERSUs") awarded to the Reporting Person on April 17, 2023, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 10,000. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 4,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001482442-26-000006 · form4-04202026_050405.xml · derivative · entry 9 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,252 Underlying: Common Stock · 4,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. F3 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 19,310 | $602.11 | $11,626,744.10 |
DisclosureSEC source: 0001482442-26-000006 · form4-04202026_050405.xml · nonDerivative · entry 6 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,998 F6 · shares: On April 17, 2026, the Reporting Person sold 19,310 shares of the Issuer's common stock on the open market at an average price of $602.11 per share. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 5,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001482442-26-000006 · form4-04202026_050405.xml · nonDerivative · entry 5 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 17, 2023, 10,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 5,000. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 11,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001482442-26-000006 · form4-04202026_050405.xml · nonDerivative · entry 4 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Pursuant to three-year performance period vesting schedule of the Earnings Per Share Performance-Based Restricted Stock Units ("ERSUs") awarded to the Reporting Person on April 17, 2023, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 10,000. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 2,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001482442-26-000006 · form4-04202026_050405.xml · nonDerivative · entry 3 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,039 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 1,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001482442-26-000006 · form4-04202026_050405.xml · derivative · entry 8 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,252 Underlying: Common Stock · 1,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 1,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends. F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 1,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 3,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001482442-26-000006 · form4-04202026_050405.xml · derivative · entry 7 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,585 Underlying: Common Stock · 3,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends. F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 736 | $0.00 | $0.00 |
DisclosureSEC source: 0001482442-26-000006 · form4-04202026_050405.xml · nonDerivative · entry 2 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 1,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001482442-26-000006 · form4-04202026_050405.xml · nonDerivative · entry 1 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | GrantEarnings Per Share Performance-Based Restricted Stock Units · Derivative | 3,339 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001482442-26-000002 · form4-04102026_040405.xml · derivative · entry 4 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,839 Underlying: Common Stock · 3,339 shares Expires not disclosed F4 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 3,339 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 3,339 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period. F4 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 3,339 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 3,339 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | GrantPerformance-Based Restricted Stock Units · Derivative | 284 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001482442-26-000002 · form4-04102026_040405.xml · derivative · entry 3 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,284 Underlying: Common Stock · 284 shares Expires not disclosed F3 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 284 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 284 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period. F3 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 284 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 284 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 251 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001482442-26-000002 · form4-04102026_040405.xml · derivative · entry 2 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,918 Underlying: Common Stock · 251 shares Expires not disclosed F2 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 251 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027. F2 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 251 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 415 | $0.00 Strike: $588.28 | $0.00 |
DisclosureSEC source: 0001482442-26-000002 · form4-04102026_040405.xml · derivative · entry 1 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,081 Underlying: Common Stock · 415 shares Expires 2036-04-08 F1 · shares: On April 8, 2026, the Reporting Person received 10-year options to purchase 415 shares of the Issuer's common stock with an exercise price of $588.28 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/8/2027. Read SEC document |
| October 09, 2025 Filed Oct 10, 2025 22:25 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 559 | $272.27 | $152,198.93 |
DisclosureSEC source: 0001482442-25-000006 · form4-10102025_101018.xml · nonDerivative · entry 4 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Held in The David and Laura Watson Foundation Disclosed balance after: 0 F3 · shares: On October 9, 2025, the David and Laura Watson Foundation sold 559 shares of the Issuer's common stock on the open market at a price of $272.27 per share. Read SEC document |
| October 09, 2025 Filed Oct 10, 2025 22:25 UTC | ARGAN INC AGX · Entity 3828 | GiftCommon Stock | 559 | $0.00 | $0.00 |
DisclosureSEC source: 0001482442-25-000006 · form4-10102025_101018.xml · nonDerivative · entry 3 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Held in The David and Laura Watson Foundation Disclosed balance after: 559 Read SEC document |
| October 09, 2025 Filed Oct 10, 2025 22:25 UTC | ARGAN INC AGX · Entity 3828 | GiftCommon Stock | 559 | $0.00 | $0.00 |
DisclosureSEC source: 0001482442-25-000006 · form4-10102025_101018.xml · nonDerivative · entry 2 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,132 F2 · shares: On October 9, 2025, the Reporting Person gifted 559 shares of the Issuer's common stock to the David and Laura Watson Foundation, a donor-advised fund administered by Raymond James Charitable. Read SEC document |
| October 09, 2025 Filed Oct 10, 2025 22:25 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 4,441 | $277.01 | $1,230,201.41 |
DisclosureSEC source: 0001482442-25-000006 · form4-10102025_101018.xml · nonDerivative · entry 1 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,691 F1 · shares: On October 9, 2025, the Reporting Person sold 4,441 shares of the Issuer's common stock on the open market at an average price of $277.01 per share. Read SEC document |
| June 11, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 17,969 | $211.02 | $3,791,818.38 |
DisclosureSEC source: 0001415889-25-016659 · form4-06112025_040609.xml · nonDerivative · entry 5 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,132 F5 · shares: On June 11, 2025, the Reporting Person sold 17,969 shares of the Issuer's common stock on the open market at an average price of $211.02 per share. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 1,000 | $61.22 Strike: $61.22 | $61,220.00 |
DisclosureSEC source: 0001415889-25-016659 · form4-06112025_040609.xml · derivative · entry 8 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,666 Underlying: Common Stock · 1,000 shares Expires 2034-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On June 9, 2025, the Reporting Portion exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,334 | $39.47 Strike: $39.47 | $131,592.98 |
DisclosureSEC source: 0001415889-25-016659 · form4-06112025_040609.xml · derivative · entry 7 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,666 Underlying: Common Stock · 3,334 shares Expires 2033-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On June 9, 2025, the Reporting Person exercised a portion of his stock option awarded on April 17, 2023 to purchase 3,334 shares of the Issuer's common stock at a price of $39.47 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,334 | $36.78 Strike: $36.78 | $122,624.52 |
DisclosureSEC source: 0001415889-25-016659 · form4-06112025_040609.xml · derivative · entry 6 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 3,334 shares Expires 2032-04-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 9, 2025 the Reporting Person exercised the remaining portion of his stock option awarded on April 18, 2022 to purchase 3,334 shares of the Issuer's common stock at a price of $36.78 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 2,031 | $230.38 | $467,901.78 |
DisclosureSEC source: 0001415889-25-016659 · form4-06112025_040609.xml · nonDerivative · entry 4 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,101 F4 · shares: On June 9, 2025, the Reporting Person sold 2,031 shares of the Issuer's common stock on the open market at an average price of $230.38 per share. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 410 | $61.22 | $25,100.20 |
DisclosureSEC source: 0001415889-25-016659 · form4-06112025_040609.xml · nonDerivative · entry 3 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On June 9, 2025, the Reporting Portion exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,533 | $39.47 | $60,507.51 |
DisclosureSEC source: 0001415889-25-016659 · form4-06112025_040609.xml · nonDerivative · entry 2 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,722 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On June 9, 2025, the Reporting Person exercised a portion of his stock option awarded on April 17, 2023 to purchase 3,334 shares of the Issuer's common stock at a price of $39.47 per share, using the net settle method. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,553 | $36.78 | $57,119.34 |
DisclosureSEC source: 0001415889-25-016659 · form4-06112025_040609.xml · nonDerivative · entry 1 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 9, 2025 the Reporting Person exercised the remaining portion of his stock option awarded on April 18, 2022 to purchase 3,334 shares of the Issuer's common stock at a price of $36.78 per share, using the net settle method. Read SEC document |
| April 18, 2025 Filed Apr 21, 2025 20:41 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 13 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 18, 2022, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 18, 2025. The target number of shares was 10,000. F4 · derivative.expiration_date: Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 18, 2022, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 18, 2025. The target number of shares was 10,000. Read SEC document |
| April 18, 2025 Filed Apr 21, 2025 20:41 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 3,334 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 12 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,667 Underlying: Common Stock · 3,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 18, 2022, 3,334 shares of Common Stock became issuable to the Reporting Person on April 18, 2025. F3 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 18, 2022, 3,334 shares of Common Stock became issuable to the Reporting Person on April 18, 2025. Read SEC document |
| April 18, 2025 Filed Apr 21, 2025 20:41 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 11,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011085 · form4-04212025_080415.xml · nonDerivative · entry 5 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 18, 2022, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 18, 2025. The target number of shares was 10,000. Read SEC document |
| April 18, 2025 Filed Apr 21, 2025 20:41 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011085 · form4-04212025_080415.xml · nonDerivative · entry 4 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 18, 2022, 3,334 shares of Common Stock became issuable to the Reporting Person on April 18, 2025. Read SEC document |
| April 17, 2025 Filed Apr 21, 2025 20:41 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 4,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 11 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,001 Underlying: Common Stock · 4,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2025. F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2025. Read SEC document |
| April 17, 2025 Filed Apr 21, 2025 20:41 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 2,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011085 · form4-04212025_080415.xml · nonDerivative · entry 3 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2025. Read SEC document |
| April 16, 2025 Filed Apr 21, 2025 20:41 UTC | ARGAN INC AGX · Entity 3828 | GrantEarnings Per Share Performance-Based Restricted Stock Units · Derivative | 7,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 10 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock · 7,500 shares Expires not disclosed F8 · derivative.exercise_date: On April 16, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 7,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2026, 2027 and 2028 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2023, 2024 and 2025. The pay-out ratio of the target number of 7,500 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period. F8 · derivative.expiration_date: On April 16, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 7,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2026, 2027 and 2028 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2023, 2024 and 2025. The pay-out ratio of the target number of 7,500 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period. Read SEC document |
| April 16, 2025 Filed Apr 21, 2025 20:41 UTC | ARGAN INC AGX · Entity 3828 | GrantPerformance-Based Restricted Stock Units · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 9 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F7 · derivative.exercise_date: On April 16, 2025, the Reporting Person was granted PRSUs in the target number of 3,000 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2025 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 3,000 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period. F7 · derivative.expiration_date: On April 16, 2025, the Reporting Person was granted PRSUs in the target number of 3,000 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2025 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 3,000 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period. Read SEC document |
| April 16, 2025 Filed Apr 21, 2025 20:41 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $148.72 | $0.00 |
DisclosureSEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 8 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,334 Underlying: Common Stock · 2,000 shares Expires 2035-04-16 F6 · shares: On April 16, 2025, the Reporting Person received 10-year options to purchase 2,000 shares of the Issuer's common stock with an exercise price of $148.72 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/16/2026. Read SEC document |
| April 16, 2025 Filed Apr 21, 2025 20:41 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 4,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 7 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,001 Underlying: Common Stock · 4,000 shares Expires not disclosed F5 · derivative.exercise_date: On April 16, 2025 the Reporting Person was granted TRSUs covering 4,000 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/16/2026. F5 · derivative.expiration_date: On April 16, 2025 the Reporting Person was granted TRSUs covering 4,000 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/16/2026. Read SEC document |
| April 16, 2025 Filed Apr 21, 2025 20:41 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 3,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011085 · form4-04212025_080415.xml · derivative · entry 6 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,001 Underlying: Common Stock · 3,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2025. F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2025. Read SEC document |
| April 16, 2025 Filed Apr 21, 2025 20:41 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011085 · form4-04212025_080415.xml · nonDerivative · entry 2 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2025. Read SEC document |
| December 23, 2024 Filed Apr 21, 2025 20:41 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 500 | $139.89 | $69,945.00 |
DisclosureSEC source: 0001415889-25-011085 · form4-04212025_080415.xml · nonDerivative · entry 1 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Held in The David and Laura Watson Foundation Disclosed balance after: 0 Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 40,000 | $64.25 Strike: $64.25 | $2,570,000.00 |
DisclosureSEC source: 0001415889-24-029969 · form4-12202024_041201.xml · derivative · entry 5 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,334 Underlying: Common Stock · 40,000 shares Expires 2027-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 18, 2024, the Reporting Person exercised his stock option awarded on April 6, 2017 to purchase 40,000 shares of the Issuer's common stock at a price of $64.25 per share, using the net settle method. Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029969 · form4-12202024_041201.xml · nonDerivative · entry 3 Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,791 F3 · shares: On December 18, 2024, the Reporting Person gifted 500 shares of the Issuer's common stock to the David and Laura Watson Foundation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.